Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer
NCT05020275
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST:
Blood Samples
Sponsor
Rennes University Hospital